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1. Introduction 
Type 1 diabetes is a chronic metabolic disease whose aetiology and pathogenesis remain not 
completely understood. Current criteria for the diagnosis of diabetes are: 1) haemoglobin 
A1c ≥ 6.5% (assayed using a method that is certified by the National Glycohemoglobin 
Standardization Program, NGSP, and standardised or traceable to the Diabetes Control and 
Complications Trial, DCCT, reference assay), 2) fasting plasma glucose (FPG) ≥ 126 mg/dl, 
3) 2-hour plasma glucose ≥ 200 mg/dl during an oral glucose tolerance test (OGTT, 75 g), 4) 
a random plasma glucose ≥ 200 mg/dl (American Diabetes Association, 2011). The 
classification of diabetes includes: type 1 diabetes, type 2 diabetes, other specific types of 
diabetes due to other causes, and gestational diabetes mellitus. Type 2 diabetes, which is 
usually associated with obesity and older age, results from insulin resistance and 
progressive failure of pancreatic beta-cell function. Type 1 diabetes, which has usually an 
abrupt onset in younger people, is an organ-specific autoimmune disease characterised by 
absolute insulin deficiency resulting from beta-cell destruction. However, autoimmunity 
may not be the primary cause: environmental triggers are believed to precipitate type 1 
diabetes in genetically susceptible individuals (van Belle et al., 2011). The overall incidence 
of type 1 diabetes is increasing; the majority of the increase is observed in the youngest age 
group, which also appeared to be the heaviest (Evertsen et al., 2009). Indeed, the accelerator 
hypothesis (Wilkin, 2009) suggests that type 1 and type 2 diabetes are the same disorder of 
insulin resistance set against different genetic backgrounds. Three processes could variably 
accelerate the loss of beta cells through apoptosis: constitution, insulin resistance, and 
autoimmunity. None of these accelerators leads to diabetes without excess weight, which 
causes an increase in insulin resistance and, thus, the weakening of glucose control. In turn, 
the glucotoxicity accelerates beta-cell apoptosis directly and by inducing beta-cell 
immunogens and autoimmunity in genetically predisposed subjects. Insulitis is commonly 
observed in recent-onset type 1 diabetes, but it does not uniformly affect all insulin-
containing islets (differences in islet function?). It has been suggested that under increased 
insulin demand (puberty, adolescence, high sugar intake, etc.) a population of islets may be 
more prone to dysfunction or death, thereby attracting antigen presenting cells and 
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promoting insulitis in susceptible individuals (Rowe et al., 2011). In a genome-wide 
association study, 41 distinct genomic locations provided evidence for association with type 
1 diabetes in the meta-analysis (Barrett et al., 2009). The Type 1 Diabetes Genetics 
Consortium (T1DGC) has recruited families with at least two siblings who have type 1 
diabetes in order to identify genes that determine an individual’s risk of type 1 diabetes. 
T1DBase is the web-based resource focused on the genetics and genomics of type 1 diabetes 
susceptibility (https://www.t1dgc.org) that provides the updated table of human loci 
associated with type 1 diabetes (Table 1).  
 
Chromosome Gene of interest Abbreviation 
1p13.2 Protein tyrosine phosphatase, non-receptor type 
22 
PTPN22 
1q31.2 Regulator of G-protein signalling 1 RGS1 
2q12 Interleukin 18 receptor accessory protein IL18RAP 
2q24.2 Interferon induced with helicase C domain 1 IFIH1 
2q33.2 Cytotoxic T-lymphocyte-associated protein 4 CTLA4 
3p21.31 Chemokine (C-C motif) receptor 5 CCR5 
4q27 Interleukin 2 IL2 
5p13   
6p21.31 
6p21.33 
Major histocompatibility complexes 
HLA-B, -A, -DRB1, 
-DQB1, -DPB1 
6q15 similar to BTB and CNC homology 1, 
basic leucine zipper transcription factor 2 
BACH2 
6q23.3 similar to Tumor necrosis factor, 
-induced protein 3 TNFAIP3 
6q25.3 T-cell activation Rho GTPase-activating protein TAGAP 
10p15.1 Interleukin 2 receptor,  IL2RA 
10p15.1 Protein kinase C,  PRKCQ 
11p15.5 Insulin II INS 
12q13.2   
12q13.3 Kinesin family member 5A KIF5A 
12q24.12   
15q25.1   
16p13.3   
18p11.21 Protein tyrosine phosphatase, non-receptor type 2 PTPN2 
18q22.2 CD226 antigen CD226 
21q22.3   
22q13.1   
 (from: http://t1dbase.org/page/PosterView/display/poster_id/386) 
Table 1. Human loci associated with type 1 diabetes. 
With regards to the causative environmental triggers that have been implicated in the 
pathogenesis of type 1 diabetes, they have been recently reviewed (van Belle et al., 2011; 
Vehik & Dabelea, 2011) and include particularly viral infections, gut microbic flora and 
other bacteria, early life feeding patterns, wheat proteins, and vitamin D. 
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2. Identifying individuals at risk for type 1 diabetes 
In Europe, the number of adults with diabetes was expected to reach 55.2 million (8.5% of 
the adult population) in 2010; about 112,000 children and adolescents were estimated to 
have type 1 diabetes mellitus (http://www.diabetesatlas.org/content/europe). 
Most diabetic cases are complex diseases resulting from interactions between genetic and 
environmental determinants in genetically predisposed individuals. Empirical evidence 
suggests a architecture of many genetic loci with many variants of small effect (Wray & 
Goddard, 2010). Genome-wide association studies have suggested that the majority of 
susceptible loci have small contributions to phenotypic variation and therefore there should 
be a large number of susceptibility loci involved in the genetic basis of complex diseases 
(consistent with the polygenic model). Moreover, the differentiation of sporadic and familial 
cases has implied that most complex diseases are genetically heterogeneous. Family history 
has a high positive predictive value, but a low negative predictive value. Yang et al. (2010) 
have shown that 1) the proportion of sporadic cases depends on disease prevalence and 
heritability of the underlying liability scale, and 2) a large proportion of sporadic cases is 
expected under the polygenic model due to the low prevalence rates of common complex 
genetic diseases. Thus, the causal mechanisms cannot be inferred from the observed 
proportion of sporadic cases alone. The prediction of disease risk to relatives from many risk 
loci or markers requires a model that combines the effects of these loci. The constrained 
multiplicative, Odds and Probit models fitted data on risk to relatives, but it is difficult to 
distinguish between them until genetic variants that explain the majority of the known 
genetic variance are identified (Wray & Goddard, 2010). Hence, genetic risk modelling to 
derive prediction of individual risk and risk to relatives are still difficult to reconcile.  
In most individuals with autoimmune type 1 diabetes, beta cell destruction is a chronically 
progressive and very slow process that starts long before overt disease. During this “silent” 
phase, autoantibodies are produced and self-reactive activated lymphocytes infiltrate the 
islets of Langerhans (Rowe et al., 2011).  Autoantibodies that target self-antigens in the 
insulin-secreting beta cells of the pancreas include: islet cell autoantibodies (ICA), 
insulinoma-associated antigen-2 antibodies (IA-2A), antibodies against the related antigen 
IA-2 beta (IA-2), insulin autoantibodies (IAA), autoantibodies to the 65kDa isoform of 
glutamic acid decarboxylase 65 (GADA), and the recently identified autoantibodies to the 
zinc transporter 8 (ZnT8A) (Table 2).  
Islet autoantibodies are potent tools for the prediction of type 1 diabetes and are the basis 
for recruitment in prevention trials and immunointervention trials. In the general childhood 
population in Finland, one-time screening for GADA and IA-2A was capable of identifying 
about 60% of those individuals who will develop type 1 diabetes over the subsequent 27 
years; both positive and negative seroconversions occurred over time reflecting a dynamic 
process of beta cell autoimmunity, but positivity for at least two diabetes-associated 
autoantibodies represented in most cases a point of no return (Knip et al., 2010). So far, 
however, the place of autoantibody-based risk assessment in routine clinical practice is 
limited because no proven therapeutic interventions is available for people at high risk of 
progression to type 1 diabetes. Until therapies modulating the disease process become 
available, the benefit to individual patients is questionable - awareness of risk is rather 
useless or even stressful - and diabetes antibody testing does not yet have a role in clinical 
care (Bingley, 2010). It is considered likely that islet-related autoantibodies are not directly 
pathogenetic, whereas autoreactive CD4 and CD8 T cells mediate beta cell damage. 
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Therefore, standardised autoantibody screenings should be combined with the detection of 
autoreactive T cells. Unfortunately, none of the currently available T cell assays satisfies all 
the features of a good assay: small blood sample required, simplicity, specificity, low intra- 
and inter-assay variability (Fierabracci, 2011). Notwithstanding recent developments based 
on immunosorbent spot and immunoblotting techniques, the International Workshops of 
the Immunology Diabetes Society concluded that T cell results are still inconclusive and 
novel approaches are currently being investigated. 
In conclusion, it may be that in the future combination screening predicts type 1 diabetes 
clinical onset, but actually genetic risk, serum autoantibody profiling and T cell assays are 
uneconomical when applied in the general population. 
 
Autoantibodies against Abbreviation Method 
38-kDa glycated islet cell membrane-
associated protein
GLIMA Immunoprecipitation 
51-kDa aromatic-L-amino-acid 
decarboxylase 
AADC Immunoprecipitation 
52-kDa rat insulinoma 52-kDa RIN Immunoblot 
Aminoacyl-tRNA synthetase ARS ELISA* 
Carbonic anydrase II CA II ELISA* 
Carboxypeptidase H CPHA Radiobinding assay 
Chymotrypsinogen-related 30-kDa 
pancreatic  
 Immunoblot analysis 
DNA topoisomerase II TopIIA ELISA* and Western blot 
Ganglioside GM2-1
GM2-1 
Indirect immunoperoxidase 
technique 
Gangliosides GM1, 2, 3, etc. *ELISA 
Glucose type-2 transporter GLUT2 Western blot 
Glutamic acid decarboxylase GADA Radiobinding assay, ELISA* 
Heat shock proteins HSP *ELISA 
Insulin  IAA Radiobinding assay 
Insulinoma-associated antigen-2 IA-2A Radiobinding assay, ELISA* 
Insulinoma-associated antigen 2 IA-2 Radiobinding assay 
Islet cell  ICA Indirect immunofluorescence 
Islet cell surface ICSA Radiobinding assay 
Proinsulin  PIAA Radiobinding assay 
Zinc transporter 8 ZnT8 Radiobinding assay 
* Enzyme linked immunosorbent assay 
Table 2. List of islet autoantibodies detected in type 1 diabetes (modified from Winter & 
Schatz, 2011). 
3. Phenotyping type 1 diabetes families  
Translational research aims to integrate basic life science (genomics, transcriptomics, 
proteomics, and metabolomics) with insights gained from clinical experience to 
comprehensively study complex biological system and complex human diseases. 
Translation requires, among others, methods that relate molecular and cellular phenotypes 
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to clinical characteristics (Bebek et al., 2011). Indeed, the correlation between quantitative 
phenotypes and traits allows for a more efficient use of the genetic information; hence the 
importance of accurate family phenotyping studies. Unaffected family members can 
contribute as much to the analysis as individuals with the disease diagnosis. For example, 
the finding of cognitive deficits in individuals with schizophrenia and in the clinically 
unaffected relatives of these individuals suggested that these deficits are part of the innate 
underlying distinct differences that make some individuals vulnerable to schizophrenia. 
Examining these complementary biological phenotypes in genetic studies has been found to 
provide valuable information about the pathway that connects genotype to clinical disease 
(Almasy et al., 2008). Similarly, large-scale genetic fine mapping and genotype-phenotype 
associations implicated polymorphisms in the IL2RA region in type 1 diabetes: IL2RA type 1 
diabetes susceptibility genotypes were associated with lower circulating levels of the 
biomarker, soluble IL-2RA (Lowe et al., 2007). However, despite the theoretical advantages 
of quantitative trait analysis and testing of multiple plausible domains, some matters have 
emerged since quantitative traits may not be the most relevant phenotypes to investigate in 
search for the genetic etiology of disease. Identifying the “best” phenotype for genetic 
studies needs to survey family members and examine coexisting features and familial 
segregation patterns. A focus on careful assessment of the most genetically relevant 
phenotypes has been recommended (Brzustowicz & Bassett, 2008). 
Over the years, our research efforts have sought primarily to gain a comprehensive 
understanding of the common phenotypic elements that characterise families with a 
sporadic case of type 1 diabetes. Here we provide a research-based overview of these 
familial peculiarities that include multifaceted, easily detectable, clinical perturbations: 
physical (BMI), cardiovascular (blood pressure response to exercise and circadian blood 
pressure pattern), biochemical (fasting plasma glucose, HbA1c, lipids, homeostasis model 
assessment of insulin sensitivity, plasma markers of oxidative damage), cellular (cellular 
markers of oxidative damage, transplasma membrane electron transport systems, 
mitochondrial membrane potential), and immunological (lymphocyte subsets).  
4. Body weight in type 1 diabetes families 
According to epidemiological findings and the accelerator hypothesis, the prevalence of 
overweight in preadolescent children is increasing, it tracks into adulthood and may 
increase diabetes and cardiovascular disease risk in adulthood. The risk of childhood 
obesity seems to increase with exposure to diabetes or cigarette smoke in utero, high birth 
weight, rapid weight gain in infancy, and shorter breastfeeding duration. The Diabetes 
Autoimmunity Study in the Young (DAISY) examined longitudinally 1,718 children from 
birth that were at increased risk for type 1 diabetes (Lamb et al., 2010). Gender, diabetes 
exposure in utero, size for gestational age, weight gain in the first year of life, and total 
breastfeeding duration (inverse) showed significant association with higher childhood BMI. 
Mediation analysis suggested that 1) the protective effect of breastfeeding duration on 
childhood BMI was largely mediated by slower infant weight gain, and 2) the increased risk 
of higher childhood BMI associated with exposure to diabetes in utero was partially 
explained by greater birth size. Maternal obesity before pregnancy and weight gain during 
pregnancy significantly predicted increased risk of persistent multiple positivity for islet 
autoantibodies in offspring with high genetic susceptibility for type 1 diabetes (Rasmussen 
et al., 2009). A systematic review and meta-analysis (12 studies) indicated that high birth 
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weight and increased weight gain during the first year of life were associated with an 
increased risk of type 1 diabetes in later life (Harder et al., 2009).  
Metabolic demand and insulin resistance have been suggested to be involved in the 
development of type 1 diabetes (Evertsen et al., 2009; Wilkin, 2009), but the evidence is 
not consistent across the studies. In 1650 prospectively followed children of mothers or 
fathers with type 1 diabetes (BABYDIAB cohort), islet autoantibodies-positive children 
were not insulin resistant (based on homeostasis model assessment of insulin resistance, 
HOMA-IR) and did not have increased BMI around and early after seroconversion 
(Winkler at al., 2009). In this study, of 777 children with HOMA-IR measurements, 84 
developed islet antibodies during the study: analysis of HOMA-IR by age showed no 
significant difference between islet autoantibody-positive and islet autoantibody-negative 
children, with a tendency towards a lower HOMA-IR in the antibody-positive children 
compared with the antibody-negative children.  
In a primary school health program in Pisa we screened 869 primary school children (448 M, 
421 F, mean age 1185 months): height, weight, four skinfolds, and four circumferences 
were measured; a family-reported questionnaire was used to determine family composition, 
history, and lifestyle (Giampietro et al., 2002). The percentages of children who could be 
considered overweight (BMI  95th percentile of age- and sex-specific National Health and 
Nutrition Examination Survey I, NHANES I, reference data) were boys, 10.0%, and girls, 
9.3%. It emerged that offspring BMI was correlated with birth weight, parental BMI and 
scholarship level, children blood pressure, and hours per day spent in television viewing. 
Family history for diabetes was associated with higher BMI, skinfold thickness at the 
subscapular area (SSF), waist circumference, and upper thigh. Family history for 
hypertension was associated with higher SSF/skinfold thickness at the triceps area (TCF) 
ratio. We concluded that anthropometric and anamnestic data on child and family yield 
more accurate estimates of risk profile: fat distribution seems relevant for metabolic and 
cardiovascular disorders. 
Since our initial investigations on type 1 diabetes families, we found that first degree 
relatives’ BMI tended to be higher when compared with healthy control subjects who had 
no first-degree relative with type 1 diabetes, although the difference did not always reach 
statistical significance (Matteucci & Giampietro, 2000a; Matteucci et al. 2004a, 2004b; 
Matteucci et al. 2006). In recent years, on the contrary, the difference in BMI between 
unaffected siblings of type 1 diabetic probands and healthy control subjects has reached the 
statistical significance (Figure 1, Matteucci et al., 2010). 
This finding probably reflects the trend toward increasing body weight and obesity in the 
general population, declining physical activity and unhealthy dietary habits that we have 
documented (Matteucci et al., 2004b, 2007, 2008). However, the emerging difference in 
BMI between unaffected relatives and control subjects suggests that additional factors are 
operative in type 1 diabetes families, which remain unknown. The single nucleotide 
polymorphism rs9939609 in the fat mass and obesity associated gene (FTO) region on 
chromosome 16q12, which increases the risk of childhood obesity and type 2 diabetes, did 
not alter susceptibility to type 1 diabetes (Field et al., 2007). Although increased early 
growth was associated with disease risk in various European populations, any role of 
infant feeding in this association remained unclear (EURODIAB Substudy 2 Study Group, 
2002). Scientific evidences suggested associations of allelic variations in the Vitamin D 
receptor gene and phenotypes related to body weight, glucose homeostasis, diabetes and 
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its vascular complications (Reis et al., 2005). Whatever the case, our data in adult members 
of type 1 diabetes families highlight that the ‘familial’ predisposition to overweight 
remains throughout life. 
 
 
Fig. 1. Body mass index (BMI) in control subjects, type 1 diabetic patients and their siblings 
(Matteucci et al., 2010). 
5. Familial cardiovascular abnormalities 
Diabetes and hypertension are strongly associated although the role of glycaemia in 
promoting hypertension is a matter of debate (Invitti, 2003). HbA1c variability predicts not 
only incident microalbuminuria and progression of established renal disease but also 
cardiovascular disease events in patients with type 1 diabetes (Wadén et al., 2009). 
Moreover, HbA1c concentration predicts cardiovascular disease and all-cause mortality in 
adults without diabetes (Khaw et al., 2004). In healthy non-diabetic and non-hypertensive 
men, fasting plasma glucose is independently associated with blood pressure at rest and 
during exercise and development of elevated blood pressure after 7-years follow-up 
(Biornholt et al., 2003). Usually, in type 1 diabetes families, parental hypertension has been 
associated with diabetic nephropathy in adult and young offspring (Viberti et al., 1987; 
Marcovecchio et al., 2010), but the familial/hereditary factors that have an impact on 
diabetic nephropathy have not been so far identified. In a large homogeneous population 
from the Finnish Diabetic Nephropathy study, a cluster of parental hypertension, 
cardiovascular disease, cardiovascular mortality, and type 1 diabetes was associated with 
diabetic nephropathy in offspring with type 1 diabetes. It seemed that the more the traits 
clustered in family, the higher the risk for diabetes nephropathy (Thorn et al., 2007).  
In this regard it is noteworthy that enhanced sodium/lithium countertransport and 
sodium/hydrogen exchange had been suggested to predict diabetic nephropathy (Walker et 
al., 1990; Ng et al, 1990). However, we found evidence contradicting this favourite 
hypothesis. Indeed, our data demonstrated convincingly that sodium/hydrogen exchange 
activity was significantly higher in type 1 diabetes with no difference among the two groups 
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of diabetic patients with and without nephropathy. Moreover, enhanced sodium/hydrogen 
exchange activity was also a common feature of nondiabetic first-degree relatives of type 1 
diabetic patients with no difference among the corresponding groups of relatives. The 
association between antiport activities of diabetic probands and their relatives suggested 
that the altered activity of the transporter was primarily determined by familial factors 
whose nature remained to be clarified (Matteucci & Giampietro, 2000b).  
Generally, the observation of raised arterial blood pressure in relatives of type 1 diabetes 
patients was based on history, a single measurement of arterial blood pressure, or a 24-h 
ambulatory record; we were first to evaluate the response to ergometer exercise 
(Matteucci et al., 2006). Blood pressure response to exercise had been evaluated as a 
predictor of future hypertension and cardiovascular disease (Sharabi et al., 2001). 
Moreover, the heritability for resting blood pressure and blood pressure response to 
exercise was under investigation (An et al., 2000). We identified an abnormal blood 
pressure response to exercise testing not only in type 1 diabetic probands but also in 
asymptomatic normotensive non-diabetic relatives of type 1 diabetics, in which it was 
associated with indices of metabolic syndrome and oxidative damage. Furthermore, in 
healthy normotensive non-diabetic control subjects without family history of type 1 
diabetes, strong associations were found 1) between resting systolic blood pressure and 
fasting plasma glucose as well as fasting plasma insulin levels, and 2) between systolic 
blood pressure response to exercise and HbA1c levels  (Matteucci et al., 2006).  
In a recent study, we performed 24-hour ambulatory blood pressure monitoring in type 1 
diabetes families with the primary aim of investigating the circadian variability of blood 
pressure and the ambulatory arterial stiffness index in healthy siblings of type 1 diabetes 
patients vs healthy control subjects who had no first-degree relative with type 1 diabetes 
(Matteucci et al., 2010). Secondary aims of the study were to explore the influence of both 
cardiovascular autonomic function and erythrocyte electron transfer activity as oxidative 
marker on the ambulatory blood pressure profile. Indeed, human erythrocytes possess a 
transplasma ferricyanide reductase activity (measured as the erythrocyte velocity of 
ferricyanide reduction) that transfers reducing equivalents from intracellular reductants to 
extracellular oxidants (Matteucci & Giampietro, 2000c) and belongs to the ubiquitous 
transplasma membrane electron transport systems. Transplasma membrane electron 
transport activities have been related to the regulation of vital cellular processes and to the 
pathogenesis of various human disorders (Lane & Lawen, 2009) and exist also in endothelial 
cells where they have been suggested to regulate redox status and possibly atherogenesis 
through regulation of haeme oxygenase-1 expression (Lee et al., 2009). 
We found that systolic blood pressure midline-estimating statistic of rhythm and pulse 
pressure were higher in type 1 diabetes patients and correlated positively with diabetes 
duration and the rate of oxidant-induced erythrocyte electron transfer to extracellular 
ferricyanide. Autonomic dysfunction was associated with diastolic blood pressure ecphasia 
and increased ambulatory arterial stiffness index. Siblings had higher BMI (Figure 1), lower 
insulin sensitivity (Figure 2), larger systolic blood pressure amplitude (Figure 3), and higher 
ambulatory arterial stiffness index than controls. Daytime systolic blood pressure was 
positively, independently associated with BMI and erythrocyte electron transfer to 
extracellular ferricyanide. Among non-diabetic people, there was a significant correlation 
between ambulatory arterial stiffness index and fasting plasma glucose. We concluded that 
siblings of type 1 diabetes patients exhibited a cluster of sub-clinical metabolic abnormalities 
associated with consensual perturbations in blood pressure variability. Moreover, our 
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findings supported, in a clinical setting, the proposed role of transplasma membrane 
electron transport systems in vascular pathobiology.  
 
 
Fig. 2. Homeostasis model assessment of insulin sensitivity (HOMA-IS) in the same study 
groups (Matteucci et al., 2010). 
 
 
Fig. 3. Systolic blood pressure amplitude (SBP-Amplitude) in the same study groups 
(Matteucci et al., 2010). 
6. Biochemical phenotype and redox balance in type 1 diabetes relatives 
Our studies over the years have linked family history of type 1 diabetes (first-degree 
kinship) with multiple biochemical abnormalities. Since 2000 we documented metabolic 
perturbations in nondiabetic relatives: parents differed from age-matched control subjects in 
the higher plasma concentrations of glucose and Lipoprotein (a); their fibrinogen was 
borderline but did not reach any statistical significance; in turn, siblings of type 1 diabetes 
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patients differed from age-matched control subjects in the higher levels of Lipoprotein (a) 
(Matteucci et al., 2000a). In the same study, we investigated the redox status and antioxidant 
defences in these families.  
The premises were the following: 
 enhanced levels of free radicals found in diabetes mellitus and impaired glucose 
tolerance has long been assumed to be related to chronically elevated glucose levels 
(Baynes and Thorpe, 1999; Vijayalingam et al., 1996), 
 oxidative stress was suggested to play a primary role in the pathogenesis of diabetes 
and its complications but Authors still discussed whether oxidation preceded the 
appearance of complications or it merely reflected their presence (Baynes and 
Thorpe, 1999).  
We suggested an alternative hypothesis, i.e. that oxidative stress preceded diabetes mellitus. 
In the case, indirect evidence for increased oxidative stress could be also detectable in non-
diabetic relatives of type 1 diabetic patients. In order to provide evidence of a familial 
imbalance between radical production and antioxidant defences, we investigated indices of 
glucose and lipid metabolism, markers of plasma and cell lipid peroxidation, a novel marker 
of oxidant-induced protein damage, and the effects of oxygen radicals on erythrocytes of 
patients with type 1 diabetes and their relatives. We measured blood creatinine, glucose, 
HbA1c, cholesterol, triglycerides, Lipoprotein (a), fibrinogen, malondialdehyde, and 
advanced oxidation protein products. Erythrocyte response to oxidative stress (3-h-
incubation at 37°C with or without a radical generating system) was evaluated by 
measuring erythrocyte glutathione, erythrocyte malodialdehyde, and haemolysis. Plasma 
and erythrocyte malodialdehyde were found to be significantly elevated in diabetics and 
relatives than in controls. Basal erythrocyte glutathione was lower in diabetics and 
incubations of cells caused in diabetics a decrease in erythrocyte glutathione of lesser degree 
than in control subjects, while a significant increase in haemolysis. Among relatives, 
haemolysis was increased both at baseline and after incubation. Plasma malodialdehyde 
was associated with blood glucose, creatinine, and fibrinogen; basal erythrocyte 
malodialdehyde with plasma Lipoprotein (a), fibrinogen, and plasma malodialdehyde. 
Basal erythrocyte glutathione content correlated with serum glucose and erythrocyte 
malodialdehyde production. 
In that occasion, we were pioneers of the research on redox balance in type 1 diabetes 
families. We presented first evidence that markers of lipoprotein metabolism (Lipoprotein 
(a)), oxidative stress (plasma and erythrocyte malodialdehyde), and cellular fragility 
(haemolysis) are abnormal in non diabetic relatives of type 1 diabetics supporting the view 
that familial elements even precede diabetes. It seemed reasonable that the same biologic 
markers considered major predictors of cardiovascular disease could also trace familial 
susceptibility to type 1 diabetes, just as they have been associated with the development of 
type 2 diabetes (Matteucci et al., 2000a). 
Based on the finding of elevated circulating markers of lipid peroxidation and increased 
cellular fragility, we decided to complete and integrate our investigation with further 
biochemical measurements of possible first-chain initiating or stimulating factors in order to 
evaluate, in the same families, the contribution of extracellular antioxidants to the increased 
oxidative stress. We also aimed to understand the eventual relationship between oxidative 
stress and the abnormal sodium/hydrogen exchange activity previously observed 
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(Matteucci et al., 2001). We were unable to find out any abnormalities in circulating metal 
ions (such as iron, transferrin, ferritin, copper, and ceruloplasmin) or extracellular 
antioxidant defences (such as serum uric acid, albumin, bilirubin,) that could favour 
oxidative stress in non-diabetic relatives of type 1 patients. On the contrary, we confirmed 
our previous finding of a generalised increase in sodium/hydrogen exchange activity. The 
rate of amiloride-sensitive hydrogen efflux from erythrocytes was significantly associated 
with both erythrocyte glutathione content and some markers of radical-induced damage 
such as plasma advanced oxidation protein products and malondialdehyde, erythrocyte 
osmotic fragility, and erythrocyte malondialdehyde accumulation under oxidative stress. 
Hence, this additional study provided the first in vivo demonstration of a significant 
association between oxidative stress and sodium/hydrogen exchange upregulation. The 
familiarly overactive sodium/hydrogen exchange itself could be viewed as further evidence 
pointing to the presence in these families of a redox disequilibrium where oxidation seems 
to be prevailing. 
Taken into account that:  
 mitochondria are the cellular site of oxidation-reduction reactions and energy transfer 
processes; mitochondrial dysfunction is believed to play a role in the development of 
diabetes and its complications because of the active generation of free radicals (Maiese 
et al., 2007),  
 a reactive oxygen species-mediated long-term 'memory' of hyperglycaemic stress has 
been reported in the mitochondria of endothelial cells (Ihnat et al., 2007), but 
impairment of mitochondrial function has been also observed in subjects with family 
history of type 2 diabetes before the onset of impaired glucose tolerance (Petersen et 
al., 2004), 
in the last step of our research we measured the mitochondrial membrane potential in 
peripheral blood granulocytes from type 1 diabetic patients and their unaffected siblings 
using the mitochondrial indicator 5,5’,6,6’-tetra chloro-1,1’,3,3’-tetraethylbenzimidazolyl-
carbocyanine iodide (JC-1) in conjunction with flow cytometry (Matteucci et al., 2011). 
This was the first study to examine mitochondrial membrane potential of circulating 
leukocytes in type 1 diabetes families and to document consistent evidence for 
mitochondrial hyperpolarisation that was highest in type 1 diabetic patients and 
intermediate in their siblings. Fasting plasma glucose was the only correlate of leukocyte 
mitochondrial membrane potential. Confirming previous observations in type 1 diabetes 
families, siblings had fasting plasma glucose slightly higher than control subjects yet 
lower HbA1c levels. The combination of higher mean fasting plasma glucose, lower 
homeostasis model assessment of insulin sensitivity (HOMA-IS) and lower HbA1c levels 
suggested that siblings had both impaired basal glucose clearance rate and enhanced 
insulin-stimulated muscle glucose disposal. 
We hypothesised that in type 1 diabetes families, radical-induced mitochondrial membrane 
potential oscillations may be synchronized toward polarized states. The positive association 
between mitochondrial membrane potential oscillations and fasting plasma glucose within 
the range from normal to dysglycemic conditions suggested that hyperglycaemic challenge 
implied increased glucose metabolisation, enhanced oxidant formation and 
hyperpolarisation of the mitochondrial membrane. 
It is noteworthy that succination of proteins, which is an irreversible chemical modification 
of cysteine by the Krebs cycle intermediate fumarate, is increased by hyperpolarisation of 
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the inner mitochondrial membrane and develops in concert with mitochondrial and 
oxidative stress in diabetes (Frizzell et al., 2011).  
7. Immunological functions in type 1 diabetes families 
Although type 1 diabetes is a T-cell–mediated autoimmune disease, until a few years ago 
relatively few studies have attempted to associate T-cell autoreactivity with disease 
progression, in comparison with efforts directed on monitoring autoantibodies, and those 
that have been performed were largely limited to CD4 T-cells (Roep, 2008). Currently, islet 
epitope-specific CD8 T cells are believed to have a pivotal role in the destruction process. 
Unfortunately, monitoring multiple epitope-specific CD8 T cell populations poses many 
technical problems. Recently, monitoring of CD8 T cells reactive to beta-cell-derived 
antigens has been performed using the combinatorial quantum dot technique, which has 
been validated using peripheral blood cells from recent-onset type 1 diabetic patients, their 
siblings, and control subjects (Velthuis et al., 2010). Moreover, during the progression of 
autoimmune diabetes, memory autoreactive regulatory CD8 T cells can be expanded that 
could effectively suppress the expansion of dominant and subdominant effectors (Khadra et 
al., 2010). Increasing evidence shows the significance of CD4 and CD8 regulatory T cells, 
expressing the marker CD25 or IL-2 receptor, in autoimmune disease models. On the 
contrary, very few study have dealt with the role of CD23 or low affinity IgE receptor. In 
2004, given that abnormalities in redox balance clustered in type 1 diabetes families and the 
intracellular redox status seemed to modulate immune function, we aimed to investigate the 
relationship between oxidative stress and immunologic features. We measured oxidative 
markers, serum pro-inflammatory cytokines, soluble cytokine receptors, and subsets of 
peripheral blood lymphocytes (by varying combinations of CD4, CD8, CD23, and CD25) 
from type 1 patients, low-risk (i.e. without underlying islet autoimmunity) non-diabetic 
first-degree relatives of diabetic patients, and healthy subjects (Matteucci et al., 2004a). In 
these families, protein and lipid oxidation was confirmed from reduced sulfhydryl groups, 
increased advanced oxidation protein products, increased plasma and erythrocyte 
malondialdehyde. Relatives had decreased counts of monocytes, of cells coexpressing CD23 
and CD25, and of CD25+ cells in peripheral blood. Patients with type 1 diabetes had similar 
defects and, in addition, showed decreased counts of peripheral CD4+CD8+ lymphocytes 
and increased serum levels of soluble receptors for IL-6 and IL-2. This was the first 
demonstration of leukocyte abnormalities in low-risk T1DM relatives, also presenting signs 
of oxidative stress. Moreover, our study reported first evidence that the oxidative stress 
observed in type 1 diabetes families was correlated to immunological hallmarks suggestive 
of different immunoregulatory mechanisms. A crucial question remained open: did the 
alteration in immune functions follow the altered intracellular redox status or vice versa? 
More recently, we have characterised CD26 expression of T cell subsets in patients with type 
1 diabetes because 1) high expression of CD26 among CD8+ T cells has been suggested to be 
a marker of effective long-term memory T cell formation typical of acute resolved viral 
infections  (Ibegbu et al., 2009), and 2) an increased risk of persistent viral infections, such as 
hepatitis C (HCV), was reported among diabetic patients (Lonardo et al., 2009).  
No significant difference was seen in percentages or absolute numbers of CD4+CD26+, 
CD4+CD26-, CD8+CD26+, and CD8+CD26- between type 1 diabetes and control people. 
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However, the fluorescence intensity of CD26 expression on CD8+ lymphocytes revealed a 
significant decrease in type 1 diabetic patients compared with control subjects. Mean 
fluorescence of CD8+CD26+ cells was inversely correlated with the absolute number of 
CD4+CD26- cells (Matteucci et al., 2010). We interpreted the finding (low expression of CD26 
among CD8+ T cells in type 1 diabetes) as indicating a defect in successfully developed long-
term memory CD8+ T cells or in CD8+ T cells activation, even though the negative 
association with the number of CD4+CD26- T cell does not support a recent activation of 
peripheral T cells. We intend to continue research in this field in consideration of the 
immunomodulating role of the multifunctional CD26 (Ohnuma et al., 2011). 
8. Concluding remarks 
Today, there is a great need to integrate molecular biology with whole organ physiology. 
Findings from molecular and cellular studies must be brought back to intact organ systems 
without loosing the physiological context (Königshoff et al., 2011). This is especially true in 
the field of metabolic diseases where the study of individual proteins and signalling 
pathways in detail may not be easily translated to the intact organism. Taken into account 
the enlarging list of phenotypic characteristics that might allow the early clinical 
identification of families possibly at risk for sporadic cases of type 1 diabetes, many 
questions await an answer. We suggest the two main (in our opinion) issues. 
 
 
Fig. 4. Some of the potential mechanisms linking metabolic syndrome and T cell maintenance. 
First question:  may insulin-resistance be the common denominator of the observed familial 
peculiarities? And therefore, second question: could an early correction of one/some of 
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these common clinical abnormalities modify the natural history of the disease and thence its 
epidemiology? The data above summarised suggest to consider also alternative ways 
beyond the traditional immuno-based interventions so far extensively investigated in the 
field of type 1 diabetes. There is increasing attention to the role of metabolic syndrome and 
immune responses as well as to the relation between the immune and neuroendocrine 
systems (Figure 4). The adipocyte-derived proinflammatory hormone leptin can affect the 
survival and proliferation of autoreactive CD4 T cells (Matarese et al., 2008; Galgani et al., 
2010). Immune and neuroendocrine systems have bidirectional communications (Kelley et 
al., 2007; Berczi et al., 2009). Growth hormone and ghrelin are expressed in immune cells, 
which in turn bear receptors for these hormones (Hattori, 2009). Leptin, ghrelin, insulin-like 
growth factor 1, insulin-like growth factor binding protein 3, and cytokines regulate both 
thymopoiesis and maintenance of T cells. Therefore, elucidation of metabolic syndrome, T 
cell metabolism, hormones, and microbiota may lead to new insights into the maintenance 
of proper immune responses (Hsu & Mountz, 2010).  
At the present state of knowledge and given the current diabetes epidemic, it would seem 
reasonable that proper, more realistic, public health interventions (by general and family 
practitioners) are designed that address general issues such as feeding, lifestyle, overweight, 
‘borderline’ blood pressure, impaired fasting glucose, etc. These health interventions, 
beyond the conventional boundaries that have for so long limited the visual field, might 
have a favourable cost-benefit ratio. 
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